These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2376472)

  • 1. Synthesis and immunosuppressive activities of conformationally restricted cyclosporin lactam analogues.
    Lee JP; Dunlap B; Rich DH
    Int J Pept Protein Res; 1990 May; 35(5):481-94. PubMed ID: 2376472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, conformation, and immunosuppressive activity of a conformationally restricted cyclosporine lactam analogue.
    Aebi JD; Guillaume D; Dunlap BE; Rich DH
    J Med Chem; 1988 Sep; 31(9):1805-15. PubMed ID: 3261799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, conformation, and immunosuppressive activities of three analogues of cyclosporin A modified in the 1-position.
    Aebi JD; Deyo DT; Sun CQ; Guillaume D; Dunlap B; Rich DH
    J Med Chem; 1990 Mar; 33(3):999-1009. PubMed ID: 2308150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, biological activity, and conformational analysis of (2S,3R,4S)-MeBmt1-cyclosporin, a novel 1-position epimer of cyclosporin A.
    Rich DH; Sun CQ; Guillaume D; Dunlap B; Evans DA; Weber AE
    J Med Chem; 1989 Aug; 32(8):1982-7. PubMed ID: 2754718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, conformation, and immunosuppressive activity of cyclosporines that contain epsilon-oxygen (4R)-4-[(E)-butenyl]-4,N-dimethyl-L-threonine analogues in the 1-position.
    Sun CQ; Guillaume D; Dunlap B; Rich DH
    J Med Chem; 1990 May; 33(5):1443-52. PubMed ID: 2329566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antimitogenic activities of four analogues of cyclosporin A modified in the 1-position.
    Rich DH; Dhaon MK; Dunlap B; Miller SP
    J Med Chem; 1986 Jun; 29(6):978-84. PubMed ID: 3712387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporins: structure-activity relationships for the inhibition of the human FPR1 formylpeptide receptor.
    Loor F; Tiberghien F; Wenandy T; Didier A; Traber R
    J Med Chem; 2002 Oct; 45(21):4613-28. PubMed ID: 12361388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporin analogs modified in the 3,7,8-positions: substituent effects on peptidylprolyl isomerase inhibition and immunosuppressive activity are nonadditive.
    Hu MK; Badger A; Rich DH
    J Med Chem; 1995 Oct; 38(21):4164-70. PubMed ID: 7473543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporins: structure-activity relationships for the inhibition of the human MDR1 P-glycoprotein ABC transporter.
    Loor F; Tiberghien F; Wenandy T; Didier A; Traber R
    J Med Chem; 2002 Oct; 45(21):4598-612. PubMed ID: 12361387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and conformation of constrained peptides with hypoglycaemic activity derived from human growth hormone.
    Ede NJ; Rae ID; Hearn MT
    Int J Pept Protein Res; 1994 Dec; 44(6):568-81. PubMed ID: 7705979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformation of MeAla6-cyclosporin A by NMR. Relationship of sidechain orientation of the MeBmt-1, MeLeu-9, and MeLeu-10 residues to immunosuppressive activity.
    Gooley PR; Durette PL; Boger J; Armitage IM
    Int J Pept Protein Res; 1991 May; 37(5):351-63. PubMed ID: 1917291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive activity of [MeBm2t]1-, D-diaminobutyryl-8-, and D-diaminopropyl-8-cyclosporin analogues correlates with inhibition of calcineurin phosphatase activity.
    Nelson PA; Akselband Y; Kawamura A; Su M; Tung RD; Rich DH; Kishore V; Rosborough SL; DeCenzo MT; Livingston DJ
    J Immunol; 1993 Mar; 150(6):2139-47. PubMed ID: 7680683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMR studies of [U-13C]cyclosporin A bound to cyclophilin: bound conformation and portions of cyclosporin involved in binding.
    Fesik SW; Gampe RT; Eaton HL; Gemmecker G; Olejniczak ET; Neri P; Holzman TF; Egan DA; Edalji R; Simmer R
    Biochemistry; 1991 Jul; 30(26):6574-83. PubMed ID: 2054356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, biological activity, and conformational analysis of peptidomimetic analogues of the Saccharomyces cerevisiae alpha-factor tridecapeptide.
    Zhang YL; Marepalli HR; Lu HF; Becker JM; Naider F
    Biochemistry; 1998 Sep; 37(36):12465-76. PubMed ID: 9730819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformationally constrained human calcitonin (hCt) analogues reveal a critical role of sequence 17-21 for the oligomerization state and bioactivity of hCt.
    Kazantzis A; Waldner M; Taylor JW; Kapurniotu A
    Eur J Biochem; 2002 Feb; 269(3):780-91. PubMed ID: 11846779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling conformational changes in cyclosporin A.
    O'Donohue MF; Burgess AW; Walkinshaw MD; Treutlein HR
    Protein Sci; 1995 Oct; 4(10):2191-202. PubMed ID: 8535256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is cyclophilin involved in the immunosuppressive and nephrotoxic mechanism of action of cyclosporin A?
    Sigal NH; Dumont F; Durette P; Siekierka JJ; Peterson L; Rich DH; Dunlap BE; Staruch MJ; Melino MR; Koprak SL
    J Exp Med; 1991 Mar; 173(3):619-28. PubMed ID: 1997649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformationally restricted PACAP27 analogues incorporating type II/II' IBTM beta-turn mimetics. Synthesis, NMR structure determination, and binding affinity.
    González-Muñiz R; Martín-Martínez M; Granata C; de Oliveira E; Santiveri CM; González C; Frechilla D; Herranz R; García-López MT; Del Río J; Angeles Jiménez M; Andreu D
    Bioorg Med Chem; 2001 Dec; 9(12):3173-83. PubMed ID: 11711293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporins from Mycelium sterilae MS 2929.
    Kuzma M; Sedmera P; Jegorov A; Havlícek V
    J Nat Prod; 2009 Jan; 72(1):159-63. PubMed ID: 19102681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a model for the delta opioid receptor pharmacophore. 1. Conformationally restricted Tyr1 replacements in the cyclic delta receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13).
    Mosberg HI; Lomize AL; Wang C; Kroona H; Heyl DL; Sobczyk-Kojiro K; Ma W; Mousigian C; Porreca F
    J Med Chem; 1994 Dec; 37(25):4371-83. PubMed ID: 7996549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.